Federal Circuit Confirms Validity Of Injectable Testosterone Patents

Mealey's (July 16, 2018, 1:39 PM EDT) -- WASHINGTON, D.C. — A Delaware federal judge’s determination, following a bench trial, that two patents relating to the injectable testosterone drug Aveed are not invalid was not erroneous, the Federal Circuit U.S. Court of Appeals ruled July 13 (Endo Pharmaceuticals Solutions Inc., et al. v. Custopharm Inc., No. 17-1719, Fed. Cir., 2018 U.S. App. LEXIS 19265)....